These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6840427)

  • 21. Chlorpropamide-alcohol flushing, aldehyde dehydrogenase activity, and diabetic complications.
    Ohlin H; Jerntorp P; Bergström B; Almér LO
    Br Med J (Clin Res Ed); 1982 Sep; 285(6345):838-40. PubMed ID: 6811034
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The alcohol-chlorpropamide test. Study and diagnostic value of changes in cutaneous temperature].
    Guillausseau PJ; Akoka C; Lubetzki J
    Presse Med; 1984 May; 13(20):1249-51. PubMed ID: 6232581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the chlorpropamide-alcohol-flush in patients with type 1 and type 2 diabetes.
    Pontiroli AE; De Pasqua A; Colombo R; Ricordi C; Pozza G
    Acta Diabetol Lat; 1983; 20(2):117-23. PubMed ID: 6880563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlorpropamide and glibenclamide serum concentrations in hospitalized patients.
    Huupponen R; Viikari J; Saarimaa H
    Ann Clin Res; 1982 Jun; 14(3):119-22. PubMed ID: 6814340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiological study of prevalence of chlorpropamide alcohol flushing in insulin dependent diabetics, non-insulin dependent diabetics, and non-diabetics.
    Ng Tang Fui S; Keen H; Jarrett RJ; Strakosch C; Murrells T; Marsden P; Stott R
    Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1509-12. PubMed ID: 6416476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose.
    Judzewitsch RG; Pfeifer MA; Best JD; Beard JC; Halter JB; Porte D
    J Clin Endocrinol Metab; 1982 Aug; 55(2):321-8. PubMed ID: 7045153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facial skin temperature in chlorpropamide alcohol flush.
    Jerntorp P
    Acta Med Scand; 1985; 217(2):229-32. PubMed ID: 3993436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blockade of chlorpropamide-alcohol flushing by indomethacin suggests an association between prostaglandins and diabetic vascular complications.
    Barnett AH; Spiliopoulos AJ; Pyke DA
    Lancet; 1980 Jul; 2(8187):164-6. PubMed ID: 6105337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma chlorpropamide: a critical factor in chlorpropamide-alcohol flush.
    Jerntorp P; Almér LO; Ohlin H; Wåhlin-Boll E; Melander A
    Eur J Clin Pharmacol; 1983; 24(2):237-42. PubMed ID: 6840174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chlorpropamide alcohol flush. Lack of specificity for familial non-insulin dependent diabetes.
    Köbberling J; Bengsch N; Brüggeboes B; Schwarck H; Tillil H; Weber M
    Diabetologia; 1980 Oct; 19(4):359-63. PubMed ID: 7000598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorpropamide-alcohol flushing and proteinuria in non-insulin-dependent diabetics.
    Barnett AH; Leslie RD; Pyke DA
    Br Med J (Clin Res Ed); 1981 Feb; 282(6263):522-3. PubMed ID: 6780109
    [No Abstract]   [Full Text] [Related]  

  • 34. Insulin responses to glucose in non-insulin-dependent diabetic subjects with and without the chlorpropamide-alcohol flush: effect of salicylate and naloxone.
    Hershon KS; Bierman EL; Bruzzone CM; Ensinck JW
    Diabetes Care; 1982; 5(4):404-8. PubMed ID: 6759079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The chlorpropamide alcohol flush test in diabetes mellitus: methods for objective evaluation.
    Jerntorp P
    Scand J Clin Lab Invest; 1983 May; 43(3):249-54. PubMed ID: 6622970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase of plasma acetaldehyde. An objective indicator of the chlorpropamide alcohol flush.
    Jerntorp P; Ohlin H; Bergström B; Almér LO
    Diabetes; 1981 Sep; 30(9):788-91. PubMed ID: 7262473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlorpropamide alcohol flushing.
    Lancet; 1981 Feb; 1(8215):336-7. PubMed ID: 6109983
    [No Abstract]   [Full Text] [Related]  

  • 38. Chlorpropamide alcohol flushing and diabetic retinopathy.
    Leslie RD; Barnett AH; Pyke DA
    Lancet; 1979 May; 1(8124):997-9. PubMed ID: 86772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Facial skin temperature and the chlorpropamide/alcohol flush in diabetics.
    Radder JK; Box MC; Lemkes HH
    Lancet; 1980 Nov; 2(8202):1037. PubMed ID: 6107672
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.